Other groups have proposed that mutant p53 accumulation negatively regulates SLC7A11 in non-brain tumor cell lines [38], although our data support the hypothesis that wild-type p53, and not null or mutant p53 PDX GBM tumor cells, possess downregulated SLC7A11 (Figure 1). This evidence concerns the gene SLC7A11 and brain neoplasm.